Sample COA — replace with live lab data per batch before going to market.
Catalog Longevity & Aging COA
Certificate of Analysis

FOXO4-DRI

D-retro-inverso FOXO4 peptide (FOXO4-p53 interference)

Batch SPC-FOX4-2412-B
Manufacture Date December 18, 2024
Expiry Date December 18, 2026
cGMP Manufacturer Helix BioSynth GmbH (Placeholder — sample data)
Testing Laboratory Analytika ISO Labs Inc. (ISO 17025 Accredited)
Lab Report ID ALI-2024-0991-FOX
Batch Number SPC-FOX4-2412-B

Test Results

All Tests Passed
Test Method Result Status
Identity HPLC Confirmed ✓ Pass
Purity HPLC-UV 99.3% ✓ Pass
Molecular Mass LC-MS 1892.2 Da (expected 1892.2) ✓ Pass
Endotoxin LAL Kinetic Chromogenic <0.1 EU/mg ✓ Pass
Sterility USP <71> Sterile — no growth ✓ Pass
Appearance Visual Inspection White lyophilized powder ✓ Pass

Reviewed & Approved

Dr. M. Stanton, PharmD — QA Lead (Placeholder)

Signed off January 6, 2025

Verify Batch SPC-FOX4-2412-B ← Back to Catalog
Physician Network

Interested in FOXO4-DRI?

A licensed physician consultation is required before any prescription. Our coordinator will match you with a physician in your state within one business day.

Request Consultation →